Literature DB >> 23908490

Greater preexisting interferon γ responses to mycobacterial antigens and lower bacillary load during HIV-associated tuberculosis.

Timothy Lahey1, Tom Czechura, Scott Crabtree, Robert D Arbeit, Mecky Matee, C Robert Horsburgh, Todd MacKenzie, Muhammad Bakari, Kisali Pallangyo, C Fordham von Reyn.   

Abstract

The role of preexisting interferon (IFN) γ responses in controlling bacillary burden in human immunodeficiency virus (HIV)-associated tuberculosis is not known. Among BCG-immunized HIV-infected adults who developed tuberculosis in a phase III trial of an investigational tuberculosis vaccine, greater baseline IFN-γ responses to early secretory antigenic target 6 and Mycobacterium tuberculosis whole-cell lysate were associated with reduced bacillary burden on sputum smear grade, days to culture positivity on agar, and sputum culture grade during subsequent tuberculosis. This association was most consistent among recipients of the investigational vaccine. When HIV-associated tuberculosis develops, greater preexisting IFN-γ responses to mycobacterial antigens are associated with reduced tuberculosis bacillary burden. ClinicalTrials.gov Identifier. NCT0052195.

Entities:  

Keywords:  HIV; antigen; interferon gamma; tuberculosis; vaccine

Mesh:

Substances:

Year:  2013        PMID: 23908490      PMCID: PMC3805244          DOI: 10.1093/infdis/jit396

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  13 in total

1.  No closure in sight for the 10/90 health-research gap.

Authors:  S Ramsay
Journal:  Lancet       Date:  2001-10-20       Impact factor: 79.321

2.  Counting antigen-specific T cells: a new approach for monitoring response to tuberculosis treatment?

Authors:  Ajit Lalvani
Journal:  Clin Infect Dis       Date:  2004-02-17       Impact factor: 9.079

3.  Interferon γ responses to mycobacterial antigens protect against subsequent HIV-associated tuberculosis.

Authors:  Timothy Lahey; Siddharth Sheth; Mecky Matee; Robert Arbeit; C Robert Horsburgh; Lillian Mtei; Todd Mackenzie; Muhammad Bakari; Jenni M Vuola; Kisali Pallangyo; C Fordham von Reyn
Journal:  J Infect Dis       Date:  2010-10-15       Impact factor: 5.226

4.  Immunogenicity of a protective whole cell mycobacterial vaccine in HIV-infected adults: a phase III study in Tanzania.

Authors:  Timothy Lahey; Robert D Arbeit; Muhammad Bakari; C Robert Horsburgh; Mecky Matee; Richard Waddell; Lillian Mtei; Jenni M Vuola; Kisali Pallangyo; C Fordham von Reyn
Journal:  Vaccine       Date:  2010-09-25       Impact factor: 3.641

Review 5.  Tuberculosis in patients with human immunodeficiency virus infection.

Authors:  D V Havlir; P F Barnes
Journal:  N Engl J Med       Date:  1999-02-04       Impact factor: 91.245

6.  Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection.

Authors:  E Jouanguy; F Altare; S Lamhamedi; P Revy; J F Emile; M Newport; M Levin; S Blanche; E Seboun; A Fischer; J L Casanova
Journal:  N Engl J Med       Date:  1996-12-26       Impact factor: 91.245

7.  Prevention of tuberculosis in Bacille Calmette-Guérin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine.

Authors:  Charles F von Reyn; Lillian Mtei; Robert D Arbeit; Richard Waddell; Bernard Cole; Todd Mackenzie; Mecky Matee; Muhammad Bakari; Susan Tvaroha; Lisa V Adams; Charles R Horsburgh; Kisali Pallangyo
Journal:  AIDS       Date:  2010-03-13       Impact factor: 4.177

8.  Completion of isoniazid preventive therapy among HIV-infected patients in Tanzania.

Authors:  P J Munseri; E A Talbot; L Mtei; C Fordham von Reyn
Journal:  Int J Tuberc Lung Dis       Date:  2008-09       Impact factor: 2.373

9.  Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy.

Authors:  Stefania Carrara; Donatella Vincenti; Nicola Petrosillo; Massimo Amicosante; Enrico Girardi; Delia Goletti
Journal:  Clin Infect Dis       Date:  2004-02-17       Impact factor: 9.079

10.  Enhanced diagnosis of HIV-1-associated tuberculosis by relating T-SPOT.TB and CD4 counts.

Authors:  T Oni; J Patel; H P Gideon; R Seldon; K Wood; Y Hlombe; K A Wilkinson; M X Rangaka; M Mendelson; R J Wilkinson
Journal:  Eur Respir J       Date:  2010-01-14       Impact factor: 16.671

View more
  1 in total

1.  Mapping of Mycobacterium tuberculosis Complex Genetic Diversity Profiles in Tanzania and Other African Countries.

Authors:  Erasto V Mbugi; Bugwesa Z Katale; Elizabeth M Streicher; Julius D Keyyu; Sharon L Kendall; Hazel M Dockrell; Anita L Michel; Mark M Rweyemamu; Robin M Warren; Mecky I Matee; Paul D van Helden; David Couvin; Nalin Rastogi
Journal:  PLoS One       Date:  2016-05-05       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.